Suppr超能文献

bcl-2、p53和Ki-67免疫反应性在移行细胞膀胱癌中的发生率及其临床病理相关性。

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

作者信息

Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos M A

机构信息

Department of Pathology, Medical School of Athens University, Greece.

出版信息

Hum Pathol. 1998 Feb;29(2):146-54. doi: 10.1016/s0046-8177(98)90225-8.

Abstract

The aim of this study was to investigate the expression of bcl-2, p53 oncoproteins, and Ki-67 antigen in a series of transitional cell bladder carcinomas and its relation to the traditional prognostic indicators and patient's survival. One hundred six cases with transitional cell carcinoma (TCC) were examined for detection of bcl-2, p53 proteins, and Ki-67 antigen (MIB1 antibody). Bcl-2 immunohistochemical positivity was observed in 52% of TCCs and in 57% of low-grade and 44% of high-grade TCCs. Bcl-2 was also detected in normal urothelium and dysplastic lesions with basal cell expression, and negative staining was observed in carcinomas in situ. Tumor stage showed a significant inverse correlation with overall bcl-2 positivity. The loss of bcl-2 protein expression in higher-stage TCCs was statistically significant (Pt = .01). p53 protein was overexpressed in 50% of TCCs and more frequently in invasive and in carcinomas in situ than in superficial TCCs (Pt = .03). In contrast, detection of p53 was not observed in normal and dysplastic urothelium. p53 positivity was related to the degree of differentiation and to the stage of the disease (Pf = .01 and Pt = .03, respectively). Concerning Ki-67 antigen, its expression was found in 57.5% of TCCs. There was a strong overall correlation of Ki-67 with tumor stage (Pt = .002) and grade (Pf = .002). Univariate statistical analysis showed that the expression of p53 and Ki-67 was significantly correlated to poor prognosis (P = .02, P = .02, respectively). On multivariate analysis, none of these markers but only stage and grade were significantly correlated to prognosis (P = .02, P = .02, respectively). These findings suggest that overexpression of bcl-2 protein may be an early event in tumorigenesis. Tumors with loss of bcl-2 positivity and overexpression of p53 and Ki-67 had an unfavorable prognosis; however, in multivariate analysis, they had no independent prognostic value.

摘要

本研究旨在探讨一系列移行细胞膀胱癌中bcl-2、p53癌蛋白及Ki-67抗原的表达情况及其与传统预后指标和患者生存率的关系。对106例移行细胞癌(TCC)病例进行检测,以检测bcl-2、p53蛋白及Ki-67抗原(MIB1抗体)。在52%的TCC中观察到bcl-2免疫组化阳性,在57%的低级别TCC和44%的高级别TCC中也观察到阳性。在正常尿路上皮和具有基底细胞表达的发育异常病变中也检测到bcl-2,原位癌中观察到阴性染色。肿瘤分期与总体bcl-2阳性呈显著负相关。在更高分期的TCC中bcl-2蛋白表达缺失具有统计学意义(Pt = 0.01)。p53蛋白在50%的TCC中过度表达,在浸润性癌和原位癌中比浅表TCC中更常见(Pt = 0.03)。相反,在正常和发育异常的尿路上皮中未观察到p53的检测。p53阳性与分化程度和疾病分期相关(分别为Pf = 0.01和Pt = 0.03)。关于Ki-67抗原,在57.5%的TCC中发现其表达。Ki-67与肿瘤分期(Pt = 0.002)和分级(Pf = 0.002)总体上有很强的相关性。单因素统计分析表明,p53和Ki-67的表达与不良预后显著相关(分别为P = 0.02,P = 0.02)。多因素分析显示,这些标志物中没有一个,但只有分期和分级与预后显著相关(分别为P = 0.02,P = 0.02)。这些发现表明,bcl-2蛋白的过度表达可能是肿瘤发生的早期事件。bcl-2阳性缺失、p53和Ki-67过度表达的肿瘤预后不良;然而,在多因素分析中,它们没有独立的预后价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验